These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2258381)

  • 21. Sertraline: a new antidepressant.
    Auster R
    Am Fam Physician; 1993 Aug; 48(2):311-4. PubMed ID: 8342482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
    Rabkin JG; Wagner G; Rabkin R
    J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sertraline (Lustral) and paroxetine (Seroxat)--new drugs for the treatment of depression.
    Drug Ther Bull; 1991 Jun; 29(12):46-7. PubMed ID: 1834449
    [No Abstract]   [Full Text] [Related]  

  • 24. Sertraline-associated syndrome of inappropriate antidiuretic hormone: case report and review of the literature.
    Bradley ME; Foote EF; Lee EN; Merkle L
    Pharmacotherapy; 1996; 16(4):680-3. PubMed ID: 8840376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of depression in advanced Alzheimer's disease using sertraline.
    Volicer L; Rheaume Y; Cyr D
    J Geriatr Psychiatry Neurol; 1994; 7(4):227-9. PubMed ID: 7826491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlling acute episodes of depression.
    Lapierre YD
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():23-35. PubMed ID: 1806627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computerized EEG correlates of depression and antidepressant treatment.
    Knott VJ; Lapierre YD
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):213-21. PubMed ID: 3306804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
    Kind B; Fattinger K; Krähenbühl S; Meier-Abt PJ
    Praxis (Bern 1994); 1996 Nov; 85(46):1490-2. PubMed ID: 8984572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale.
    Scott TF; Nussbaum P; McConnell H; Brill P
    Neurol Res; 1995 Dec; 17(6):421-2. PubMed ID: 8622794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic therapy for major depressive disorder: selection of an antidepressant.
    Preskorn SH; Burke M
    J Clin Psychiatry; 1992 Sep; 53 Suppl():5-18. PubMed ID: 1522080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bupropion and amitriptyline in the treatment of depressed patients.
    Chouinard G
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):121-9. PubMed ID: 6406440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL; Clissold SP
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of valine on 5-HT neurotransmission and mood.
    Cowen PJ; Williamson DJ; McTavish SF
    Adv Exp Med Biol; 1996; 398():67-71. PubMed ID: 8906242
    [No Abstract]   [Full Text] [Related]  

  • 37. Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system.
    Sanders-Bush E; Breeding M; Knoth K; Tsutsumi M
    Psychopharmacology (Berl); 1989; 99(1):64-9. PubMed ID: 2550988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord.
    Taiwo YO; Fabian A; Pazoles CJ; Fields HL
    Pain; 1985 Apr; 21(4):329-337. PubMed ID: 4000684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment: Serotonin syndrome associated with combined sertraline-amitriptyline treatment.
    Alderman CP; Lee PC
    Ann Pharmacother; 1996 Dec; 30(12):1499-500. PubMed ID: 8968471
    [No Abstract]   [Full Text] [Related]  

  • 40. LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.
    Markel H; Lee A; Holmes RD; Domino EF
    J Pediatr; 1994 Nov; 125(5 Pt 1):817-9. PubMed ID: 7965440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.